Recently, CR Zizhu under CR Pharmaceutical has passed WHO PQP and cGMP inspection. As an inspection sponsored by WHO according to its cGMP and TRS requirements on toxic and hazardous pharmaceuticals manufacturing, which was also an ERP site review carried out by UNFPA on CR Zizhu, was attached great importance to by SFDA.

CR Zizhu passing this inspection indicates it has won tickets for WHO and UNFPA'S bids. Henceforth, CR Zizhu will be listed among WHO PQP enterprises, and qualified to provide eligible BPC and preparations to the UN Procurement Division and other international procurement institutions, which will lay a solid foundation for CR Zizhu to go international and explore international markets.